Suzanne Thornton-Jones

Suzanne Thornton-Jones has a wide range of experience in regulatory affairs and quality control. Suzanne'smost recent role is as the Senior Vice President of Regulatory Affairs and Quality at Genprex, Inc., which they started in 2023. Prior to that, they served as the Vice President of Regulatory Affairs at Tavanta Therapeutics from 2022 to 2023 and at Affinia Therapeutics from 2021 to 2022. From 2017 to 2021, Suzanne held the position of Executive Director of Regulatory Affairs and Compliance at the Gene Therapy Program at the University of Pennsylvania. Before that, they worked at AbbVie as the Director of Global Regulatory Strategy, Regulatory Affairs from 2014 to 2017. Suzanne also has experience at sanofi-aventis, where they held various director-level roles in R&D Global Regulatory Affairs from 2006 to 2014. Suzanne'searlier experience includes working as a Pharmacology/Toxicology Reviewer at CDER from 2000 to 2005 and as a Manager and Study Director at Huntingdon Life Sciences from 1998 to 2000.

Suzanne Thornton-Jones earned their Ph.D. in Pharmacology and Toxicology from Virginia Commonwealth University School of Medicine between 1994 and 1997.